Beskidzkie Centrum Onkologii
Public municipal hospital in Bielsko-Biała, Poland, delivering multi-specialty general medicine alongside an oncology franchise (radiotherapy, nuclear medicine, chemo, surgical oncology) to Beskid-region patients under NFZ reimbursement.
- Company typePrivate
- Founded-
- HeadquartersBielsko-Biała, Poland
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Beskidzkie Centrum Onkologii does
Beskidzkie Centrum Onkologii – Szpital Miejski im. Jana Pawła II is a public municipal hospital located in Bielsko-Biała, southern Poland, serving the Beskid region. The facility operates across three sites — ul. Wyzwolenia 18 (inpatient), ul. Wyspiańskiego 21 (outpatient specialty clinics), and ul. Emilii Plater 17 — and combines a multi-specialty general hospital profile with a focused oncology franchise spanning medical oncology, surgical oncology, radiotherapy, chemotherapy, nuclear medicine, and supportive/palliative care. Adjacent service lines include obstetrics and maternity (with 500 births recorded by June 2026), cardiology and cardio-oncology, and gastroenterology, supported by a Breast Cancer Unit and a Colon Cancer Unit.
The hospital's underlying technology base is centered on capital-intensive diagnostic and therapeutic equipment: a linear accelerator for radiotherapy, a D-SPECT gamma camera, a brachytherapy unit, a semiconductor radiojod system (one of only five such installations in Poland), and what is described as the first DECT scanner in the region. It has held academic hospital status since March 2021 through a partnership with WST Katowice, and maintains ISO 9001, CMJ, and DNV GL accreditations alongside a renewed five-year NFZ public-payer authorization running April 2026 through April 2031.
The business model is that of a publicly funded municipal hospital: the dominant revenue stream is reimbursement from the Narodowy Fundusz Zdrowia (NFZ) under contract authorization, supplemented by a smaller, undisclosed private fee-for-service channel. Customers are individual patients of the Beskid region referred through NFZ pathways, with secondary relationships to academic and teaching partners. Leadership is headed by Director Krzysztof Bestwina, with a 2026 refresh appointing Dr. Rafał Wiśniowski as Deputy Director for Medical Affairs, Prof. Krzysztof Nowosielski to lead gynecologic oncology, and Danuta Wawak as Chief Nurse.
Beskidzkie Centrum Onkologii firmographics
Firmographics- Name
- Beskidzkie Centrum Onkologii
- Legal name
- Beskidzkie Centrum Onkologii – Szpital Miejski im. Jana Pawła II w Bielsku-Białej
- Website
- https://onkologia.bielsko.pl
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Public municipal hospital in Bielsko-Biała, Poland, delivering multi-specialty general medicine alongside an oncology franchise (radiotherapy, nuclear medicine, chemo, surgical oncology) to Beskid-region patients under NFZ reimbursement.
- Ownership category
- akta.pro rank
Beskidzkie Centrum Onkologii industry classification
Industry- Product category
- Oncology Hospital Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Hospitals (622)
- SIC
- Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro industry
- Oncology & Cancer Specialty HospitalsHealthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty CareHospital-Integrated Cancer Centers (Acute Oncology Programs)Radiation OncologyMedical Oncology
Keywords
Where Beskidzkie Centrum Onkologii is headquartered
LocationHeadquarters
- HQ city
- Bielsko-Biała
- HQ country
- Poland
- HQ region
- Europe
Offices3 records
Markets served
Beskidzkie Centrum Onkologii business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- National Health Fund (NFZ) Reimbursement: As a public hospital, BCO-SM's primary revenue comes from reimbursed healthcare services provided under contract with Narodowy Fundusz Zdrowia (NFZ), Poland's national health insurer. The hospital holds a 5-year NFZ authorization (April 2026 – April 2031) covering all provided healthcare services. Services are provided at no direct cost to patients covered by the public insurance system.
- Fee-for-Service (Private Patients): The hospital publishes fee schedules (cennik) for services, indicating the availability of private-pay services for patients not covered by public insurance or requesting services outside NFZ coverage.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Public healthcare services covered by NFZ (National Health Fund) - at no direct cost to insured patients |
Go-to-market motion1 record
Distribution channels6 records
Marketing channels6 records
Beskidzkie Centrum Onkologii product offering
Product offeringCore offering
BCO-SM is a municipal public hospital providing comprehensive oncology diagnosis and treatment (surgical oncology, radiotherapy, brachytherapy, chemotherapy, nuclear medicine) integrated with general hospital services including obstetrics/gynecology, neonatal care, cardiology/cardio-oncology, palliative care, and diagnostic imaging. Specialized oncology pathways are delivered through dedicated Breast Cancer Unit and Colon Cancer Unit. Services are delivered primarily under contract with Poland's National Health Fund (NFZ) and supplemented by private-pay services per published fee schedules.
Product overview
Beskidzkie Centrum Onkologii – Szpital Miejski im. Jana Pawła II is a multi-specialty hospital providing comprehensive oncology services alongside general and specialized medical care. The facility operates as a platform of specialized departments and units, with oncology (including surgical oncology, radiotherapy, chemotherapy, and nuclear medicine) as the core offering, complemented by diagnostic imaging (CT, MRI, mammography, dual-energy CT), pathomorphology, palliative care, obstetrics/gynecology with oncological gynecology, and cardiology/cardio-oncology services. Key specialized units include the Breast Cancer Unit and Colon Cancer Unit. The hospital also provides patient-facing digital services through eCareMed and Medyczny Portal Informacyjny platforms for online appointment registration.
Differentiator
Problem solved
Functional benefit
Products and services
- Oncology Treatment Services (Oddział Onkologiczny) Comprehensive cancer diagnosis and treatment including chemotherapy, radiotherapy, and surgical oncology services for various cancer types, serving NFZ-insured and private patients.
- Radiotherapy Department (Zakład Radioterapii) Radiation therapy treatments using advanced high-energy linear accelerator technology for precise cancer treatment.
- Brachytherapy Unit (Pracownia Brachyterapii) Internal radiation therapy services, positioned among the best-equipped brachytherapy units in Poland.
- Nuclear Medicine Department (Zakład Medycyny Nuklearnej) Diagnostic and therapeutic nuclear medicine services including SPECT/CT imaging, D-SPECT cardiac imaging, and personalized radioiodine (Radiojod) treatment for thyroid conditions achieving >90% efficacy.
- Breast Cancer Unit Specialized unit for comprehensive breast cancer diagnosis and treatment, integrating mammography, MRI, mammotomic biopsy, and surgical services.
- Colon Cancer Unit Specialized unit for colorectal cancer screening, diagnosis, and treatment.
- Obstetrics and Gynecology with Oncological Gynecology Obstetric services including delivery care, gynecological services, and specialized oncological gynecology treatments including robotic surgery; recorded 500 births in 2026 as of June 2026.
- Diagnostic Imaging (Zakład Diagnostyki Obrazowej) Advanced medical imaging services including CT, MRI, mammography, ultrasound, and dual-energy CT (DECT).
- Medical Physics Department (Zakład Fizyki Medycznej) Medical physics support for radiotherapy planning and quality assurance in radiation treatment.
- Pathomorphology Department (Zakład Patomorfologii) Histopathological and cytological diagnostics for cancer diagnosis.
- Analytical Laboratory (Laboratorium Analityczne) Clinical laboratory testing services including coagulation analyzers (Sysmex CS-1600) for patient diagnostics.
- Palliative Care (Opieka Paliatywna) Inpatient palliative care unit, palliative medicine outpatient clinic, and home palliative care team (Hospicjum Domowe).
- Cardiology and Cardio-Oncology Department Cardiology services including cardiac CT, echocardiography, Holter monitoring, and specialized cardio-oncology care for cancer patients.
- eCareMed Online Appointment Registration Online appointment registration platform for patient convenience in scheduling hospital visits.
- Medyczny Portal Informacyjny (MPI) Medical information portal providing online registration and access to patient services.
Quantifiable outcome
- Over 90% efficacy in radical radiojod (radioiodine) treatment for hyperthyroidism
- +1 more outcomes
Companies that use Beskidzkie Centrum Onkologii
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles3 records
Beskidzkie Centrum Onkologii technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature7 records
Beskidzkie Centrum Onkologii partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Wyższa Szkoła Techniczna w Katowicach (WST) - Faculty of Medical SciencescoreSince March 1, 2021, BCO-SM hosts Katedry i Oddziały Kliniczne (Chairs and Clinical Departments) of the Faculty of Medical Sciences of Wyższa Szkoła Techniczna in Katowice at the Zabrze campus. This academic partnership integrates clinical care with medical education and research, with the first students attending from April 12, 2021. This is a significant organizational achievement confirming the hospital's high quality standards and enabling medical student training within the facility.
- Narodowy Fundusz Zdrowia (NFZ) - National Health FundcoreBCO-SM operates under a 5-year authorization from NFZ (April 2026 – April 2031) to provide healthcare services. NFZ is Poland's national health insurer and the primary payer for the hospital's services. The authorization process included detailed verification of the hospital's operations, staff qualifications, equipment, and compliance with quality and safety standards.
Scale indicators8 records
Recent moves6 records
Expansion highlights5 records
Beskidzkie Centrum Onkologii competitors and assessment
Company assessmentBroad incumbents
- European Institute of Oncology (IEO): Milan-based specialty oncology hospital and research center offering comprehensive cancer care with strong nuclear medicine and radiotherapy capabilities. Comparable in clinical model though materially larger and privately affiliated.
- Karolinska Comprehensive Cancer Center: Academic cancer center within Karolinska University Hospital in Stockholm, combining oncology specialty care with research and education. Comparable in academic hospital status, multi-modality cancer services, and nuclear medicine capabilities.
Direct peers
- Świętokrzyskie Centrum Onkologii: Holy Cross Cancer Center in Kielce, a regional specialty oncology hospital serving a defined Polish catchment area. Comparable in scale, multi-modality offerings, and NFZ-funded public hospital structure.
- Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie: Poland's largest national oncology reference center in Warsaw, explicitly referenced as a comparable institution for BCO-SM's semiconductor-based radioiodine capability. Operates as the premier specialty oncology hospital in Poland with a similar multi-modality clinical model.
- Wielkopolskie Centrum Onkologii: Greater Poland Cancer Center in Poznań, one of Poland's leading regional oncology specialty hospitals. Comparable as a multi-site public oncology center with similar diagnostic, treatment, and research integration.
- Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii: Lower Silesian specialty oncology center in Wrocław providing comprehensive cancer care including radiotherapy, chemotherapy, and surgical oncology. Highly comparable in regional specialty hospital positioning and public payer model.
- Centrum Onkologii im. prof. Tadeusza Koszarowskiego: Regional specialty oncology center in Krakow providing surgical oncology, radiotherapy, chemotherapy, and nuclear medicine services. Closely comparable in scope, public-hospital status, and regional referral role to BCO-SM.
Regional players
- Uniwersyteckie Centrum Kliniczne im. prof. K. Gibińskiego: Academic medical center in Katowice (Silesian Voivodeship) hosting oncology services and serving as a clinical partner of the same medical faculty network as BCO-SM. Comparable academic-affiliation model and overlapping patient catchment.
- Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie: Polish multi-specialty public hospital with significant oncology and surgical programs in Krakow. Comparable in being a regional public hospital with NFZ authorization and a mix of general and oncology services.
Others
- Centrum Diagnostyki i Leczenia Nowotworów Piersi (Breast Cancer Units network): Network of dedicated breast cancer diagnostic and treatment units across Polish hospitals certified under national oncology pathways. Comparable as a structural peer for BCO-SM's Breast Cancer Unit operating model within the public system.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Beskidzkie Centrum Onkologii social profiles
Digital presenceBeskidzkie Centrum Onkologii compliance and trust
Trust signalCompliance4 records
Beskidzkie Centrum Onkologii financial estimates
Financial estimateRevenue estimate
Valuation estimate
Beskidzkie Centrum Onkologii leadership team
Management profileNumber of profiles
Profiles6 records
Beskidzkie Centrum Onkologii funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Beskidzkie Centrum Onkologii M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Beskidzkie Centrum Onkologii
What does Beskidzkie Centrum Onkologii do?
BCO-SM is a municipal public hospital providing comprehensive oncology diagnosis and treatment (surgical oncology, radiotherapy, brachytherapy, chemotherapy, nuclear medicine) integrated with general hospital services including obstetrics/gynecology, neonatal care, cardiology/cardio-oncology, palliative care, and diagnostic imaging. Specialized oncology pathways are delivered through dedicated Breast Cancer Unit and Colon Cancer Unit. Services are delivered primarily under contract with Poland's National Health Fund (NFZ) and supplemented by private-pay services per published fee schedules.
Is Beskidzkie Centrum Onkologii a public or private company?
Beskidzkie Centrum Onkologii is a private company. It is classified as state government owned and is currently operating.
When was Beskidzkie Centrum Onkologii founded?
Beskidzkie Centrum Onkologii was founded in -1. It employs 11 to 50 people.
Where is Beskidzkie Centrum Onkologii based?
Beskidzkie Centrum Onkologii is headquartered in Bielsko-Biała, Poland, in the Europe region.
How does Beskidzkie Centrum Onkologii make money?
Two revenue lines are on record. National Health Fund (NFZ) Reimbursement is the primary driver. The others are fee-for-Service (Private Patients).
Who are Beskidzkie Centrum Onkologii's main competitors?
Broad incumbents on record are European Institute of Oncology (IEO) and Karolinska Comprehensive Cancer Center. Direct peers are Świętokrzyskie Centrum Onkologii, Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie, Wielkopolskie Centrum Onkologii, Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii and Centrum Onkologii im. prof. Tadeusza Koszarowskiego. Regional players are Uniwersyteckie Centrum Kliniczne im. prof. K. Gibińskiego and Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie. Centrum Diagnostyki i Leczenia Nowotworów Piersi (Breast Cancer Units network) is listed as an others.
Does Beskidzkie Centrum Onkologii have an API?
No public API is recorded for Beskidzkie Centrum Onkologii.
What industry is Beskidzkie Centrum Onkologii in?
Beskidzkie Centrum Onkologii's product category is Oncology Hospital Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAFAAAM, Hospital-Integrated Cancer Centers (Acute Oncology Programs). Its NAICS code is 622310 and its SIC code is 8060.